Responses
Therapeutics
Randomised controlled trial
In patients hospitalised with acute heart failure, nesiritide, compared with placebo, is not associated with improvements in dyspnoea or 30-day rehospitalisation or mortality
Compose a Response to This Article
Other responses
No responses have been published for this article.